Non-Coding RNA in Tumor Cells and Tumor-Associated Myeloid Cells—Function and Therapeutic Potential
International Journal of Molecular Sciences · 02.07.2024 · 25 (13) · 7275
DOI: 10.3390/ijms25137275 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.07.2024. Verfasst von Amanda Katharina Binder und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany. Hauptthemen laut MEDLINE: Neoplasms, Myeloid Cells, RNA, Untranslated. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 211 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ERA-NET TRANSCAN, Deutsche Forschungsgemeinschaft, European Unions' Horizon Europe research and innovation programme.
Abstract (Originalsprache)
The RNA world is wide, and besides mRNA, there is a variety of other RNA types, such as non-coding (nc)RNAs, which harbor various intracellular regulatory functions. This review focuses on small interfering (si)RNA and micro (mi)RNA, which form a complex network regulating mRNA translation and, consequently, gene expression. In fact, these RNAs are critically involved in the function and phenotype of all cells in the human body, including malignant cells. In cancer, the two main targets for therapy are dysregulated cancer cells and dysfunctional immune cells. To exploit the potential of mi- or siRNA therapeutics in cancer therapy, a profound understanding of the regulatory mechanisms of RNAs and following targeted intervention is needed to re-program cancer cells and immune cell functions in vivo. The first part focuses on the function of less well-known RNAs, including siRNA and miRNA, and presents RNA-based technologies. In the second part, the therapeutic potential of these technologies in treating cancer is discussed, with particular attention on manipulating tumor-associated immune cells, especially tumor-associated myeloid cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.
- Comprehensive Cancer Center Erlangen European Metropolitan Area of Nuremberg (CCC ER-EMN), 91054 Erlangen, Germany.
- Deutsches Zentrum Immuntherapie (DZI), 91054 Erlangen, Germany.
- Bavarian Cancer Research Center (BZKF), 91054 Erlangen, Germany.
ORCID-Profile: Amanda Katharina Binder, Franziska Bremm, Jan Dörrie, Niels Schaft
Förderung
- ERA-NET TRANSCAN
- Deutsche Forschungsgemeinschaft
- European Unions' Horizon Europe research and innovation programme
- BMBF
- European Unions’ Horizon Europe research and innovation program
Zitieren
APA
Binder, A. K., Bremm, F., Dörrie, J., & Schaft, N. (2024). Non-Coding RNA in Tumor Cells and Tumor-Associated Myeloid Cells—Function and Therapeutic Potential. International Journal of Molecular Sciences, 25(13), 7275. https://doi.org/10.3390/ijms25137275
Vancouver
Binder AK, Bremm F, Dörrie J, Schaft N. Non-Coding RNA in Tumor Cells and Tumor-Associated Myeloid Cells—Function and Therapeutic Potential. International Journal of Molecular Sciences. 2024;25(13):7275. doi:10.3390/ijms25137275
BibTeX
@article{Binder2024,
author = {Binder, Amanda Katharina and Bremm, Franziska and Dörrie, Jan and Schaft, Niels},
title = {Non-Coding RNA in Tumor Cells and Tumor-Associated Myeloid Cells—Function and Therapeutic Potential},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {13},
pages = {7275},
doi = {10.3390/ijms25137275}
}
EUVIMED